Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bristol vets to benchmark farm animal medicine use
"This project will provide the beef industry with tools required to achieve and even exceed the RUMA targets" - Dr Kristen Reyher.
Project will provide beef industry with tools to achieve RUMA targets

A new project to quantify and compare farm animal medicine use across UK beef farms has been launched by the University of Bristol.

The project, ‘Strategies to benchmark and communicate farm medicine use in cattle operations,’ will begin this summer and run for 18 months. Funded by AHDB Beef & Lamb, it will see farmers given the tools and information needed to accurately assess, record and benchmark their medicine use.

An estimated 700,000 people are killed by drug-resistant infections every year. The responsible use of farm animal medicines is key to combatting the growing problem of antimicrobial resistance (AMR).

To maintain animal health and ensure safe and sustainable food production, farmers and veterinary surgeons must demonstrate responsible and evidence-based farm medicine usage. However, beef producers face challenges in achieving recent RUMA targets for medical use, as significant gaps in data exist regarding quantities and types of medicines used.

In the project, researchers from Bristol Veterinary School will lead the way with farmers and veterinary surgeons to combat AMR by changing antimicrobial use on farms. 

“This project will provide the beef industry with tools required to achieve and even exceed the RUMA targets, while demonstrating and communicating the gains made to consumers, processors, retailers and policymakers,” explains Dr Kristen Reyher from Bristol Veterinary School.

The study will be funded by the agriculture and horticulture development board AHDB Beef & Lamb and involve a range of industry advisors, including the University of Edinburgh and The Veterinary Medicines Directorate.  

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.